Cardiovascular medicine has seen rapid change over the past few years showing no signs of a slowdown. With recent developments in front-end design and implementation of new technologies for cardiovascular treatments, the cardio sector is expected to gain greater strength within the medical device industry. We'll continue to see innovative treatment technologies for cardiovascular disease in areas like transcatheter aortic valve replacement (TAVR), mitral valve replacement, and structural heart. But, future areas of progress include a larger role for wearable and implantable devices and the data they collect. 3D imaging and 3D printing will continue to be important as well. Topics to be covered include:
• Developments and challenges in cardiovascular medicine.
• What's driving new and innovative technology projects from early concept ideation to clinical feasibility studies.
• What barriers to market entry exist for medical device manufacturers.
Director, Research and Education, Center for Valve and Structural Heart Disease
Minneapolis Heart Institute
Paul Iaizzo, PhD, FHRS
Professor, Visible Heart® Research
University of Minnesota Visible Heart® Lab
Vice President of Research & Business Development, AFSolutions Business